Clinical management of methadone dependence during pregnancy

Journal of Perinatal and Neonatal Nursing

Volumn 14, Issue 4, 2001, Pages 26-45

  Wilbourne, Paula ^a   Wallerstedt, Cheryl ^a   Dorato, Veronica ^a   Curet, Luis B ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Methadone; Neonatal withdrawal; Pregnancy

Indexed keywords

METHADONE;

DRUG EFFECT; FEMALE; FETUS; HUMAN; NEWBORN; NURSING; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

FEMALE; FETUS; HUMANS; INFANT, NEWBORN; METHADONE; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0035295660     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200103000-00004     Document Type: Article

References (108)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Preliminary Estimates from the 1995 National Household Survey on Drug Abuse. Rockville, MD: US Department of Health and Human Services. Public Health Service, 1996.
2. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Preliminary Estimates from the 1996 National Household Survey on Drug Abuse. Rockville, MD: US Department of Health and Human Services. Public Health Service, 1997.
3. NIDA. National Pregnancy and Health Survey: Drug use among women delivering live births: 1992. (Publication No. 96-3819). Bethesda, MD: National Institutes of Health, 1996.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: 1994.
5. Center for Substance Abuse Treatment. State methadone treatment guidelines. (Treatment Improvement Protocol Series, 1). Rockville, MD: US Department of Health and Human Services, 1993.
6. Dole VP, Nyswander ME. A medical treatment of diacetylmorphine (heroin) addiction. JAMA. 1965;193:646-650.
7. Gearing FR, Schweitzer MD. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am J Epidemiol. 1974;100:101-112.
8. Kreek MJ. Medical safety and side effects of methadone in tolerant individuals. JAMA. 1978;223(6):665-668.
9. Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;118:304-309.
10. Center for Substance Abuse Treatment. Treatment of opiate addiction with methadone. (Technical Assistance Publication Series, 7). Rockville, MD: US Department of Health and Human Services, 1994.
11. DePetrillo PB, Rice JM. Methadone dosing and pregnancy: Impact on program compliance. Int J Addict. 1995;30(2):207-217.
12. Rementeria JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynec. 1973;116:1152-1156.
13. Anderson Garcia A. Maternal drug abuse: Laws and ethics as agents of just balances and therapeutic interventions. Int J Addict. 1993;28(13):1311-1339.
14. Janke S. Dilemmas and dialogue: Mandatory drug testing of pregnant women. Childbirth Instructor Magazine. 1994:12-18.
15. Whieford LM, Vitucci J. Pregnancy and addiction: Translating research into practice. Soc Sc Med. 1997;44(9):1371-1380.
16. Finnegan LP. Treatment issues for opioid-dependent women during the perinatal period. J Psychoactive Drugs. 1991;23(2):191-201.
17. Merikangas KR. The genetic epidemiology of alcoholism. Psychol Med. 1990; 20(1):11-20.
18. Kreek MJ, Schecter A, Gutjahr CL, Bowen E, Field T, Queenan J, Merkatz I. Analyses of methadone and other drugs in maternal and neonatal body fluids: Use in evaluation of symptoms in a neonate of a mother maintained on methadone. Am J Drug Alcohol Abuse. 1974;1:409-419.
19. Coles CD, Platzman KA. Behavioral development in children prenatally exposed to drugs and alcohol. Int J Addict. 1993;28(3):1393-1433.
20. Sanders RC, Blackmon LR, Hogge WA, Wulfsberg EA. Structural and fetal abnormalities: The total picture. St. Louis, MO: Mosby, 1996.
21. Ostrea EM, Chavez CJ. Prenatal problems (excluding withdrawal) in maternal drug addiction: A study of 830 cases. J Pediatr. 1979;94:292-295.
22. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int J Addict. 1993;28(3):1341-1391.
23. Briggs GG, Freeman RK, Yaffe JJ. A reference guide to fetal and neonatal risk: Drugs in pregnancy & lactation. 3rd ed. Baltimore, MD: Williams & Wilkins, 1993.
24. Luthar SS, Walsh KG. Treatment needs of the drug addicted mother: Integrated parenting and psychotherapy interventions. J Subst Abuse Treatment. 1995;12(5):341-348.
25. Chez R. Battering during pregnancy. In: Cherry SH, Merkatz IR, eds. Complications of pregnancy: Medical, surgical, gynecologic, psychosocial, and perinatal. 4th ed. Baltimore, MD: Williams and Wilkins, 1991.
26. Goldenberg RL, Gotlieb SJ. Social and psychological factors and pregnancy outcome. In: Cherry SH, Merkatz IR, eds. Complications of pregnancy: Medical, surgical, gynecologic, psychosocial, and perinatal. 4th ed. Baltimore, MD: Williams and Wilkins, 1991.
27. Patterson CM, Roderick P. Obstetric outcome in homeless women. BMJ. 1990; 301(6746):263-266.
28. Campbell J, Torres S, Ryan J, King C, Campbell DW, Stallings RY, Fuchs SC. Physical and nonphysical partner abuse and other risk factors for low birth weight among full term and preterm babies: a multiethnic case-control study. Am J Epdemiol. 1999;150(7):714-726.
29. Shumway J, O'Campo P, Gelen A, Witter FR, Khouzami AN, Blakemore KJ. Preterm labor, placental abruption, and premature rupture of membranes in relation to maternal violence or verbal abuse. J Matern Fetal Med. 1999;8(3):76-80.
30. Deisher RW, Litchfield C, Hope KR. Birth outcomes of prostituting adolescents. J Adolesc Health. 1991;12(7):528-533.
31. Cordero L, Hines S, Shelby KA, Landon MB. Duration of incarceration and perinatal outcome. Obstet Gynecol. 1991;78(4): 641-645.
32. Thame M, Wilks RJ, McFarlane-Anderson N, Bennett F, Forrester TE. Relationship between maternal nutritional status and infant's weight and body proportions at birth. Eur J Clin Nutr. 1997;51(3):134-138.
33. Green M, Silverman I, Suffet F, Taleporos E, Turkel WV. Outcomes of pregnancy for addicts receiving comprehensive care. Am J Drug Alcohol Abuse. 1979;6(4):413-429.
34. Rosner MA, Keith L, Chasnoff I. The Northwestern University Drug Dependence Program: The impact of intensive prenatal care on labor and delivery outcomes. Am J Obstet Gynecol. 1982;144(1): 23-27.
35. Edelin KC, Gurganious L, Golar K, Oellerrch E, Kyei-Aboagye K, Adel-Hamid M. Methadone maintenance in pregnancy: Consequences to care and outcome. Obstet Gynecol. 1988;71(3):399-404.
36. Chavkin W, Allen M, Oberman M. Drug abuse and pregnancy: Some questions on public policy and clinical management and maternal and fetal rights. Birth. 1991;18:107-112.
37. Allen PM, Sandler M. Critical components of obstetric management of chemically dependent women. Clin Obstet Gynecol. 1993;36(2):347-359.
38. Nelson-Zlupco L, Kauffman E, Morrison-Dore M. Gender differences in implications for social work intervention with substance abusing women. Social Work. 1995;40(6):45-54.
39. Poland ML, Dombrowski MP, Ager JW, Sokol RJ. Punishing pregnant drug users: enhancing flight from treatment. Drug Alcohol Depend. 1993;31(3):199-203.
40. Norbek JS, Anderson NJ. Life stress, social support, and anxiety in mid- and late-pregnancy among low income women. Res in Nurs Health. 1989;12:281-287.
41. Pasco JM, Chessare J, Baugh E, Urich L, Ialongon N. Help with prenatal household tasks and newborn birth weight: is there an association? J Dev Behav Pediatr. 1987;8(4):207-212.
42. Schaffer MA, Lia-Hoagberg B. Effects of social support on prenatal care and health behaviors of low-income women. J Obstet Gynecol Neonatal Nurs. 1997;26(4):433-440.
43. Norbeck JS, DeJoseph JF, Smith RT. A randomized trial of an empirically-derived social support intervention to prevent low birthweight among African Americans. Soc Sci Med. 1996;43(6):947-954.
44. McClellan AT. Guide to the ASI: Background, administration and field testing results. Rockville, MD: US Department of Health and Human Services, Public Health Service Alcohol, Drug Abuse and Mental Health Administration. National Institute on Drug Abuse, 1985.
45. May PA, Hymbaugh KJ, Aase JM, Samet JM. Epidemiology among American Indians of the Southwest. Soc Biol. 1983;30(4):374-387.
46. Center for Substance Abuse Treatment. Pregnant substance using women (Treatment Improvement Protocol Series, 2). Rockville, MD: US Department of Health and Human Services, 1995.
47. Berstein E, Berstein J, Levenson S. Project ASSERT: An ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Ann Emerg Med. 1997;30(2):181-189.
48. Butler CC, Rollnick S, Bachman M, Russell I, Stott N. Motivation consulting versus brief advice for smokers in general practice: a randomized trial. J Gen Pract. 1999;49:611-619.
49. Senft RA, Polen MR, Freeborn DK, Hollis JF. Brief intervention in a primary care setting for hazardous drinkers. Am J Prev Med. 1997;13(6):464-470.
50. Saunders B, Wilkenson C, Phillips M. The impact of a brief motivation intervention with opiate users attending a methadone program. Addiction. 1995;90:15-424.
51. Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol. 1999;60(2):285-287.
52. Chazotte C, Youchah JR, Harris-Allen M, et al. Substance abuse curriculum for obstetricians and gynecologists. New York: March of Dimes; 1995.
53. Botelho RJ, Novak S. Dealing with substance misuse, abuse and dependency. Prim Care. 1993;20(1):51-70.
54. Luborsky L, McLellan AT, Wooky GE, O'Brien CP, Auerbach A. Therapist success and its determinants. Arch Gen Psychiatry. 1985;42:602-611.
55. Miller WR. The addictive behaviors: Treatment of alcoholism, drug abuse, smoking, and obesity. New York: Pergamon Press, 1980.
56. Valle SK. Interpersonal functioning of alcoholism counselors and treatment outcome. J Stud Alcohol. 1980;42:279-284.
57. Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behaviors.
58. Miller WR. Rediscovering fire: Small interventions, large effects. Psych Addic Beh. 2000;14(1):6-18.
59. Fiorentine R, Hillhouse MP. Drug treatment effectiveness and client-counselor empathy. J Drug Issues. 1999;29(1):59-74.
60. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: Effects and management. Obstet Gynecol Clin North Am. 1998;25(1):139-151.
61. Miller WR, Andrews NR, Wilbourne PL, Bennett ME. A wealth of alternatives: Effective treatments for alcohol problems. In: Miller WR, Heather N, eds. Treating addictive behaviors. 2d ed. New York, 1998.
62. Anyaegbunam A, Tran T, Jadali D, Randolph G, Mikhail MS. Assessment of fetal wellbeing in methadone-maintained pregnancies: Abnormal non-stress tests. Gynecol Obstet Invest. 1997;433:25-28.
63. Levine AS, Rebarber A. Methadone maintenance treatment and the nonstress test. J Perinatol. 1995;15(3):229-231.
64. Wittman BK. A comparison of the effects of single and split dose methadone administration on the fetus: ultrasound evaluation. Int J Addict. 1991;26(2):213-218.
65. Swift RM, Dubley M, DePetrillo P, Camara D, Griffiths W. Altered methadone pharmacokinetics in pregnancy: Implications for dosing. J Subst Abuse. 1989;1(4):453-460.
66. Wang E. Methadone treatment during pregnancy. JOGNN. 1999;28(6):615-621.
67. Cejtin HE, Mills A, Swift EL. Effect of methadone on the biophysical profile. J Reprod Med. 1996;41(11):819-822.
68. Wilbourne PL, Dorato V, Miller WR, Curet LB. Benzodiazepine use and methadone use are associated with longer neonatal withdrawal in poly-substance exposed infants. Poster session presented at the annual meeting of the Society for Maternal Fetal Medicine, Miami Beach, FL; February 2000.
69. Glantz JC, Woods JR. Cocaine, heroin, and phencyclidine: Obstetric perspectives. Clin Obstet Gynecol. 1993;36(2):279-295.
70. Finnegan LP, Wapner RJ. Narcotic addiction in pregnancy. In: Drug abuse in pregnancy. Philadelphia: Lea & Febiger, Co: 1987.
71. Rajegowda BK, Glass L, Evans HE, Maso G, Swarts DP. Methadone withdrawal in newborn infants. J Pediatr. 1972; 81(3):532-534.
72. Allen MH. Detoxification considerations in the medical management of substance abuse in pregnancy. Bull N Y Acad Med. 1991;67(3):270-276.
73. Harper RG, Solish G, Feingold E, Gersten-Woolf NB, Sokol MM. Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol. 1977;129(4):417-424.
74. Malpas TJ, Darlow BA, Lennox R, Horwood LJ. Maternal methadone dosage and neonatal withdrawal. Aust NZ J Obstet Gynecol. 1995;910:175-177.
75. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976;44(4:1):642-645.
76. Mack G, Giles TD, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health. 1991; 27(2):96-100.
77. Kandall SR, Albin S, Gartner LM, Lee DS, Eidelman A, Lowinson J. The narcotic-dependent mother: Fetal and neonatal consequences. Early Hum Dev. 1997;1(2):159-169.
78. Rosen TS, Pippenger CE. Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addict Dis. 1975;2(1-2):169-178.
79. Stimmel B, Goldberg J, Reisman A, Murphy RJ, Teets D. Fetal outcome in narcotic-dependent women: The importance of the type of maternal narcotic used. Am J Drug Alcohol Abuse. 1983; 9(4):383-395.
80. Strauss ME, Andresko M, Stryker JC, Wardell JN. Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse. 1976;3(2):339-345.
81. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977;127(2):199-201.
82. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221-226.
83. Kandall SR. Treatment strategies for drug-exposed neonates. Clin Perinatol. 1999; 26(1):231-243.
84. Bell J, Chan J, Kuk A. Investigating the influence of treatment philosophy on outcome on methadone maintenance. Addiction. 1995;90:823-830.
85. Caplehorn JRM, Bell J, Kleinbaum DG, Gebski VJ. Methadone dose and heroin use during maintenance treatment. Addiction. 1993;88:119-124.
86. Caplehorn JRM, Stella M, Dalton YN, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994;89: 203-207.
87. Hulse GK, Milne E, English DR, Holman CDJ. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997; 92(11):1571-1579.
88. Wang E. Methadone treatment during pregnancy. JOGNN. 1999;28(6):615-622.
89. Zuspan FP, Gumpel JA, Mejie-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol. 1977;122(1):43-61.
90. Richardson BS, O'Grady JP, Olsen GD. Fetal breathing movements and the response to carbon dioxide in patients on methadone maintenance. Am J Obstet Gynec. 1984;150:400-405.
91. Armstrong LL, Ingrim NB, Lance LL. Lexi-Comp's clinical reference library: Drug information handbook. Hudson (Cleveland): American Pharmaceutical Association, 1994.
92. Brown HL, Britton KA, Mahaffey D, Brizendne E, Hiett K, Turnquest MA. Methadone maintenance in pregnancy: A reappraisal. Am J Obstet Gynecol. 1998; 179(2):459-463.
93. Connaughton J, Reeser J, Shotz J, Finnegan L. Perinatal addiction: Outcome and management. Am J Obstet Gynec. 1977;129: 679-686.
94. Kaye M, Chasnoff I. Substance abuse in pregnancy. In: Knuppel R, Drukker J, eds. High risk pregnancy, a team approach. Philadelphia: WBS, 1993.
95. Woods JR. Adverse consequences of prenatal illicit drug exposure. Curr Opin Obstet Gynecol. 1996;8(40):3-11.
96. Hoegerman G, Schnoll S. Narcotic use in pregnancy. Clin Perinatol. 1991;18(1):51-76.
97. Miller JM, Bourdeaux MC. A study of antenatal cocaine use-chaos in action. Am J Obstet Gynecol. 1999;18(6):1427-1431.
98. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 1989;84:924-936.
99. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93(1):137-150.
100. Howard CR, Lawerence RA. Breastfeeding and drug exposure. Obstet Gynecol Clin North Am. 1998;25(1):195-217.
101. Blinick G, Inturris CE, Jerez E, Wallach RC. Methadone assays in pregnant women and their progeny. Am J Obstet Gynecol. 1975;121:617-621.
102. Finnegan LP, Kaltenbach KA. Neonatal abstinence syndrome. In: RA Hoekelman, SB Friedman, NM Nelson, HM Seidel, eds. Primary pediatric care. 2d ed. St. Louis, MO: Mosby, 1992.
103. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis. 1975;2(1-2):141-158.
104. Maichuk GT, Zahorodny W, Marshall R. Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. J Perinatol. 1999;19(7):510-513.
105. Center for Substance Abuse Treatment. Improving treatment for drug-exposed infants (Treatment Improvement Protocol Series 5). Rockville, MD: US Department of Health and Human Services, 1993.
106. Kron RE, Litt M, Phoenix MD, Finnegan LP. Neonatal narcotic abstinence: Effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior. J Pediatr. 1976;88:637-641.
107. Carin I, Glass L, Parekh A, Solomon N, Steigman J, Wong S. Neonatal methadone withdrawal: Effects of two treatment regimens. Am J Dis Child. 1983;137:1166-1169.
108. Marcus J, Hands SL, Jeremy RJ. A longitudinal study of offspring born to methadone-maintained women: Effects of multiple risk factors on development at 4, 8, and 12 months. Am J Drug Alcohol Abuse. 1984;10(2):195-207.